四氢生物蝶呤

Tetrahydrobiopterin is an essential cofactor in the synthesis of dopamine, norepinephrine, and serotonin.
这是一种在多巴胺、去甲肾上腺素和血清素合成中必不可少的辅酶。
Deficiency of tetrahydrobiopterin can lead to disorders such as phenylketonuria and homocystinuria.
四氢生物蝶呤缺乏可能导致苯丙酮尿症和同型胱氨酸尿症等疾病。
The enzyme dihydrofolate reductase (DHFR) plays a crucial role in the regeneration of tetrahydrobiopterin.
还原型二氢叶酸还原酶（DHFR）在四氢生物蝶呤的再生过程中起关键作用。
Pharmacological treatment for depression often includes selective serotonin reuptake inhibitors (SSRIs), which require adequate levels of tetrahydrobiopterin for efficacy.
抗抑郁药物，如选择性5-羟色胺再摄取抑制剂（SSRIs），其效果往往依赖于足够的四氢生物蝶呤水平。
Inborn errors of metabolism involving tetrahydrobiopterin can be diagnosed through newborn screening tests.
涉及四氢生物蝶呤的代谢遗传病可以通过新生儿筛查测试来诊断。
Researchers have found that tetrahydrobiopterin supplementation may improve cognitive function in individuals with certain neurological conditions.
研究发现，对某些神经状况患者补充四氢生物蝶呤可能改善认知功能。
The bioavailability of tetrahydrobiopterin can be influenced by factors like diet and genetic variations.
四氢生物蝶呤的生物利用度可能受到饮食和遗传变异等因素的影响。
A balanced intake of vitamins B6, B9, and B12 is necessary for the proper production and recycling of tetrahydrobiopterin.
为了正常产生和回收四氢生物蝶呤，需要均衡摄入维生素B6、B9和B12。
Scientists are exploring the potential of tetrahydrobiopterin as a therapeutic target for treating aging-related cognitive decline.
科学家正在探索四氢生物蝶呤作为治疗与年龄相关的认知衰退的潜在靶点。
The administration of tetrahydrobiopterin precursors can be beneficial for individuals with pheochromocytoma, a condition characterized by excessive production of catecholamines.
给四氢生物蝶呤前体的患者服用可能会有益于患有嗜铬细胞瘤（一种产生过多儿茶酚胺的病症）的人。